GLOW
Multi-peptide research blend supplied for in-vitro cell-culture study.
Every lot of GLOW is analysed against the specification below before any vial is released.
| Parameter | Result | Method | |
|---|---|---|---|
| Appearance | White lyophilised powder | Visual | White lyophilised powder |
| GHK-Cu | ≥ 99.00% | HPLC | ≥ 95% |
| BPC-157 | ≥ 99.00% | HPLC | ≥ 95% |
| TB-500 (thymosin β4) | ≥ 99.00% | HPLC | ≥ 95% |
| Identity | Confirmed | HPLC / MS | Meets specification |
| Heavy metals | Not detected | ICP-MS | Pass |
| Sterility | No growth | PCR | Pass |
| Endotoxin | Within limit | USP <85> | Report |
Analysis is carried out on every lot before release. If you are supplying material onward, run your own confirmatory testing on arrival — our work supports yours, it does not replace it.
- Presentation
- 70 mg / vial
- GHK-Cu
- CAS 49557-75-7
- BPC-157
- CAS 137525-51-0
- TB-500 (thymosin β4)
- CAS 77591-33-4
- Grade
- Research use only (RUO)
You'll sign in at checkout — free, and takes a moment.
Buy 2, get the 3rd 60% off. Buy 4, get 2 free — applied automatically at checkout. Or take 20% off with code PEAKSALE.
For laboratory and research purposes only. Not for human or animal consumption.
Peer-reviewed research on GLOW, indexed in PubMed. Listed so you can read the primary sources directly.
- Pharmaceuticals (Basel)Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review
Józwiak M, Bauer M, Kamysz W et al.
- Pharmaceuticals (Basel)Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System
Sikiric P, Seiwerth S, Skrtic A et al.
- HSS JEmerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ et al.
- Pharmaceuticals (Basel)Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review
Bajramagic S, Sever M, Rasic F et al.
- Pharmaceuticals (Basel)Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function
Sikiric P, Gojkovic S, Krezic I et al.
- Pharmaceuticals (Basel)Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions
Sikiric P, Kokot A, Kralj T et al.
- Int ImmunopharmacolThymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies
Bock-Marquette I, Maar K, Maar S et al.
- Int ImmunopharmacolThymosin beta 4: A potential novel adjunct treatment for bacterial keratitis
Sosne G, Berger EA
These papers are the published research on this molecule. They are not a claim about this product, and nothing here describes an intended use. All material is supplied for laboratory research only.